| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows From Operating Activities | ||||||||||||
Net loss | ||||||||||||
-5,450 | -5,241 | -4,649 | -5,333 | -5,932 | -6,183 | -4,321 | -3,319 | -3,429 | -2,162 | -884 | -976 | -1,106 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||||||
Depreciation and amortization | ||||||||||||
28 | 6 | 3 | 2 | 2 | 2 | 5 | 6 | 5 | 13 | -0 | 6 | 6 |
Stock-based compensation | ||||||||||||
583 | 578 | 476 | 424 | 1,032 | 500 | 462 | 1 | 650 | 199 | 206 | 3 | 3 |
Changes in operating assets and liabilities: | ||||||||||||
Prepaid expenses and other current assets | ||||||||||||
189 | -200 | -172 | 9 | 427 | -165 | 54 | -114 | 320 | -97 | 116 | 0 | 14 |
Accounts payable | ||||||||||||
-288 | -53 | -130 | -335 | 551 | 669 | 117 | 173 | 302 | -75 | -209 | -104 | 333 |
Accrued compensation | ||||||||||||
-568 | 325 | 153 | 20 | -495 | 912 | 0 | 0 | 0 | - | - | - | - |
Accrued expenses and other current liabilities | ||||||||||||
-32 | 164 | 113 | 85 | -630 | -211 | 332 | -17 | 400 | -66 | 180 | 28 | -91 |
Deferred rent | ||||||||||||
-0 | -0 | 0 | 1 | 1 | 39 | 2 | 0 | 0 | - | - | - | - |
Net Cash Used In Operating Activities | ||||||||||||
-5,917 | -4,020 | -3,858 | -5,143 | -5,896 | -4,105 | -3,574 | -3,040 | -2,390 | -1,993 | -824 | -1,044 | -868 |
Cash Flows From Investing Activities | ||||||||||||
Purchases of property and equipment | ||||||||||||
93 | - | - | - | 0 | - | - | - | - | 6 | -6 | -2 | 12 |
Net Cash Used In Investing Activities | ||||||||||||
-93 | - | - | - | 0 | - | - | - | - | -6 | 6 | 2 | -12 |
Cash Flows From Financing Activities | ||||||||||||
Proceeds from sale of units in private placement | ||||||||||||
5,569 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Repayment of short-term note payable | ||||||||||||
52 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Payment of private placement issuance costs | ||||||||||||
1 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Payment of initial public offering issuance costs | ||||||||||||
- | - | - | - | - | 0 | 0 | 0 | 345 | 114 | 81 | 0 | 0 |
Proceeds from sale of common stock in public offering | ||||||||||||
- | - | - | - | - | 0 | -25,089 | 0 | 25,089 | 0 | 0 | 0 | 0 |
Proceeds from exercise of stock options | ||||||||||||
0 | 0 | 0 | 67 | 483 | 0 | 56 | 0 | 0 | - | - | - | - |
Net Cash Provided By Financing Activities | ||||||||||||
5,515 | 0 | 12,958 | 67 | 483 | 2,817 | 56 | 0 | 24,743 | -156 | 6,759 | 0 | 0 |
Net Decrease in Cash | ||||||||||||
-496 | -4,143 | 9,056 | -5,075 | -5,412 | - | - | - | - | - | - | - | - |
Supplemental Disclosure of Cash Flow Information: | ||||||||||||
Interest expense | ||||||||||||
1 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Income taxes | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Net (Decrease) Increase in Cash and Cash Equivalents | ||||||||||||
- | - | - | - | - | - | - | - | 22,352 | -2,156 | 5,942 | -1,042 | -881 |
Supplemental Disclosure of Non-Cash Investing and Financing Activities | ||||||||||||
Accrual of private placement offering costs | ||||||||||||
115 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Purchase of insurance premium financed by short-term note payable | ||||||||||||
475 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Exercise of warrants on a cashless basis | ||||||||||||
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
Conversion of convertible preferred stock into common stock | ||||||||||||
- | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reversal of previously accrued initial public offering issuance costs | ||||||||||||
- | - | - | - | - | 0 | 0 | 0 | -133 | 0 | 0 | 0 | 0 |
Reduction of additional paid-in capital for initial public offering issuance costs that were previously paid | ||||||||||||
- | - | - | - | - | - | 0 | 0 | -195 | - | 0 | 0 | 0 |